Back
H. Lundbeck AS Vs. Aligos Therapeutics Industry Stock Comparison
Sell
46
HLUBF
H. Lundbeck AS
Last Price:
5.25
Seasonality Move:
3.47%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
33.28
Seasonality Move:
10.65%
Sell
46
H. Lundbeck AS (HLUBF)
is a Sell
Is H. Lundbeck AS a Buy, Sell or Hold?
- The current H. Lundbeck AS [HLUBF] share price is $5.25. The Score for HLUBF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- HLUBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HLUBF Stock Price Chart
What is H. Lundbeck AS's stock price today?
-
The H. Lundbeck AS share price today is $5.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HLUBF is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
HLUBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 28.16 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.19 - 5.43) | Sell |
Bollinger Bands (100): | (5.17 - 5.97) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.85 | Buy |
Relative Strength Index (14 RSI): | 78.88 | Buy |
Chaikin Money Flow: | -127407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.12 - 28.52) | Buy |
Bollinger Bands (100): | (7.57 - 20.11) | Buy |
HLUBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.24 | Buy |
20-day SMA: | 5.28 | Sell |
50-day SMA: | 5.44 | Sell |
200-day SMA: | 4.86 | Buy |
8-day EMA: | 5.25 | Buy |
20-day EMA: | 5.29 | Sell |
50-day EMA: | 5.41 | Sell |
200-day EMA: | 5.07 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.4 | Buy |
20-day SMA: | 24.33 | Buy |
50-day SMA: | 15.25 | Buy |
200-day SMA: | 15.91 | Buy |
8-day EMA: | 29.74 | Buy |
20-day EMA: | 24.86 | Buy |
50-day EMA: | 18.75 | Buy |
200-day EMA: | 16.3 | Buy |
H. Lundbeck AS Earnings Growth & HLUBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
H. Lundbeck AS Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |